In today’s highly regulated pharmaceutical industry, promotional and non-promotional materials must meet the highest standards of scientific accuracy, compliance, and trust. With growing scrutiny from regulators, healthcare professionals, and the public, fact-checking has become a strategic imperative, not just a compliance checkbox.
Our latest white paper, “The Strategic Value of Medical & Scientific Fact-Checking in Medical, Legal and Regulatory Review,” highlights why rigorous fact-checking matters and covers:
- Key regulatory requirements
- Best practices for promotional fact-checking
- The cost-benefit of robust review processes
- A real-world case study showcasing fact-checking support for a global biopharmaceutical company
Misleading or unsubstantiated claims can lead to regulatory penalties, reputational damage, and patient harm. By embedding fact-checking into MLR workflows, pharma companies can safeguard patient safety, uphold brand integrity, and build lasting trust.
Download the full white paper now and learn how to optimize your medical review process for accuracy and compliance.
Author
Mary Mehrabian, PharmD, BCGP, BCMAS
Associate Director of Global Content Development and Medical Review
Mary Mehrabian is the Associate Director, Global Head of Content Development and Medical Review at EVERSANA, leading teams of medical writers, medical fact checkers, medical reviewers, and MLR coordinators in the United States, Europe,…
Vaishnavi Gowda holds a doctorate in Microbiology and has been working as a Promotional Fact Checker since 2020. She has extensive experience reviewing both promotional and non-promotional materials for U.S. and global markets, ensuring…
Mike currently serves as Senior Vice President of Medical affairs at EVERSANA. With 20+ years of healthcare and pharmaceutical industry experience in multiple leadership roles, he holds extensive experience in medical information, medical communications,…